Search Results  for '600332.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

02 Sep 2015 Thomson Reuters Stock Report 11 $25.00

Thomson Reuters Stock Report - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

02 Sep 2015 Thomson Reuters Stock Report 11 $25.00

Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd: Downgraded to Below Average

01 Sep 2015 Sadif Analytics Prime 3 $10.00

ValuEngine Industry Report for Medical-Biomed/Genetics(GZPHY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Aug 2015 ValuEngine, Inc. 10 $49.00

白云山(00874.HK)半年纯利增长15%至7.75亿,各项业务均录得稳定增长

一、 重要提示 1.1 廣州白雲山醫藥集團股份有限公司(「本公司」)半年度報告摘要摘自本公司截至2015 年6 月30 日止六個月(「本報告期」)的2015年半年度報告全文,投資者欲瞭解詳細內容,應當仔細閱讀 將刊載於上海證券交易所(「上交所」...

17 Aug 2015 Guotai JunAn (HK) Research 40 $414.00

Wright Investors Service Comprehensive Report for Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Aug 2015 Wright Reports 56 $75.00

Is There Long-Term Value in Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd?

14 Aug 2015 Sadif Analytics Prime 12 $25.00

Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd: Upgraded to Above Average

02 Jul 2015 Sadif Analytics Prime 3 $10.00